Pathophysiology of immune-mediated (type 1) diabetes mellitus - Potential for immunotherapy

被引:8
作者
Abel, M [1 ]
Krokowski, M [1 ]
机构
[1] Med Univ Lodz, Inst Paediat, Immunopathol Lab, PL-91738 Lodz, Poland
关键词
D O I
10.2165/00063030-200115050-00002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Type 1 diabetes mellitus is a chronic T cell-mediated disease resulting from autoimmune destruction of pancreatic p-cells. This process leads to progressive and irreversible failure of insulin secretion. Development of the disease involves both genetic and environmental factors. Genetic predisposition is mainly connected with the human leucocyte antigen (HLA) region, which encodes structures responsible for antigen presentation. A comprehensive molecular understanding of the pathogenesis of the disease is essential for the design of rational and well tolerated means of prevention. This paper describes recent experimental and clinical findings and elucidates the current possibilities for immunotherapy of type 1 diabetes. The nature of breakdown of self-tolerance and the mechanisms involved in its recovery are discussed.
引用
收藏
页码:291 / 301
页数:11
相关论文
共 143 条
[1]   IL-1α, IL-1β, and IFN-γ mark β cells for Fas-dependent destruction by diabetogenic CD4+ T lymphocytes [J].
Amrani, A ;
Verdaguer, J ;
T'hiessen, S ;
Bou, S ;
Santamaria, P .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (04) :459-468
[2]  
[Anonymous], 1996, DIABETES, V45, P1289
[3]  
[Anonymous], 1995, DIABETES, V44, P968
[4]   A DIFFERENTIAL-AVIDITY MODEL FOR T-CELL SELECTION [J].
ASHTONRICKARDT, PG ;
TONEGAWA, S .
IMMUNOLOGY TODAY, 1994, 15 (08) :362-366
[5]  
ASSAN R, 1985, LANCET, V1, P67
[6]  
ATKINSON M, 1994, J ENDOCRINOL INVEST, V17, P581, DOI 10.1007/BF03347753
[7]   The role of clonal deletion and anergy in oral tolerance [J].
Benson, JM ;
Whitacre, CC .
RESEARCH IN IMMUNOLOGY, 1997, 148 (8-9) :533-541
[8]   Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells [J].
Bergerot, I ;
Arreaza, GA ;
Cameron, MJ ;
Burdick, MD ;
Strieter, RM ;
Chensue, SW ;
Chakrabarti, S ;
Delovitch, TL .
DIABETES, 1999, 48 (09) :1720-1729
[10]   COMBINED ANALYSIS OF AUTOANTIBODIES IMPROVES PREDICTION OF IDDM IN ISLET-CELL ANTIBODY-POSITIVE RELATIVES [J].
BINGLEY, PJ ;
CHRISTIE, MR ;
BONIFACIO, E ;
BONFANTI, R ;
SHATTOCK, M ;
FONTE, MT ;
BOTTAZZO, GF ;
GALE, EAM .
DIABETES, 1994, 43 (11) :1304-1310